China Baoan (000009.SZ): The company's subsidiary, Mayinglong, operates hospital-based medical services.

Gelonghui, June 8 — China Baoan (000009.SZ) stated on an investor interaction platform that its subsidiary Mayinglong operates hospital diagnosis and treatment services.

Gelonghui FinanceJun 8 15:08

Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops

MT NewswiresMay 25 15:56

MAYINGLONG (600993): Earnings in Line with Expectations, Stable Operations Highlight Intrinsic Value

Event Description: On April 24, 2026, the company released its 2025 annual report and its first-quarter 2026 report. In 2025, the company generated revenue of RMB 3.867 billion, an increase of 3.72% year-over-year; attributable net

Changjiang SecuritiesMay 24 19:52

Mayinglong (600993.SH): Controlling subsidiary terminates the transfer of equity in its subordinate controlling company.

Gelonghui, May 8th ┃ Ma Yinglong (600993.SH) announced that on March 27, 2026, its controlling subsidiary, Ma Yinglong Medical Management Co., Ltd. (hereinafter referred to as 'Ma Yinglong Medical' or 'Transferor'), signed an Equity Transfer Agreement with Zhuo Zhun Technology Co., Ltd. (hereinafter referred to as 'Zhuo Zhun Technology' or 'Transferee'). Ma Yinglong Medical intends to transfer its capital contribution of RMB 61,058,000 in Beijing Ma Yinglong Evergreen Hospital Management Co., Ltd. (hereinafter referred to as 'Beijing Medical') to Zhuo Zhun Technology, representing 79.8144% of Beijing Medical’s registered capital. The transaction price is RMB 10.

Gelonghui FinanceMay 8 15:37

Express News | Ma Yinglong: Controlling subsidiary terminates the transfer of equity in its subsidiary company.

BreakingsMay 8 15:34

Mayinglong\'s First Quarter Report for 2026

SZSIApr 25 00:00 · Announcements